San Diego-centered Viking Therapeutics marked by itself as a significant competitor within the weight loss drug current market in February just after revealing promising knowledge from a mid-stage demo of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when supplied as a weekly injection As well as in M